Literature DB >> 4382401

Infrared identification of pharmaceutically important sulphonamides with particular reference to the occurrence of polymorphism.

R J Mesley, E E Houghton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4382401     DOI: 10.1111/j.2042-7158.1967.tb08090.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  5 in total

Review 1.  Some aspects of the influence of formulation on the bioavailability of drugs from solid dosage forms.

Authors:  O I Corrigan; R F Timoney
Journal:  Ir J Med Sci       Date:  1974-07       Impact factor: 1.568

2.  Nonamorphism in flufenamic acid and a new record for a polymorphic compound with solved structures.

Authors:  Vilmalí López-Mejías; Jeff W Kampf; Adam J Matzger
Journal:  J Am Chem Soc       Date:  2012-06-12       Impact factor: 15.419

3.  Amorphous solid dispersions of sulfonamide/Soluplus® and sulfonamide/PVP prepared by ball milling.

Authors:  Vincent Caron; Yun Hu; Lidia Tajber; Andrea Erxleben; Owen I Corrigan; Patrick McArdle; Anne Marie Healy
Journal:  AAPS PharmSciTech       Date:  2013-02-07       Impact factor: 3.246

4.  Synthesis, Antibacterial and Lipoxygenase Inhibition Studies of N-(Alkyl/aralkyl)-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-methylbenzenesulfonamides.

Authors:  Muhammad Athar Abbasi; Aziz-Ur Rehman; Sabahat Z Siddiqui; Anam Sheeza; Sumaira Nazir; Irshad Ahmad; Rabia Malik; Syed Aa Shah
Journal:  Turk J Pharm Sci       Date:  2017-04-15

5.  Crystal polymorphism and spectroscopical properties of sulfonamides in solid state by means of First Principles calculations.

Authors:  C Ignacio Sainz-Díaz; Alexander Pérez de la Luz; Carolina Barrientos-Salcedo; Misaela Francisco-Márquez; Catalina Soriano-Correa
Journal:  J Comput Aided Mol Des       Date:  2022-07-26       Impact factor: 4.179

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.